Cubist Systematic Strategies, LLC Graphite Bio, Inc. Transaction History

Cubist Systematic Strategies, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$2.82 - $3.59 $4,526 - $5,761	-1,605 Reduced 10.31%	13,968 $46,000
Q3 2022 Nov 14, 2022	SELL	$2.82 - $4.24 $150,633 - $226,483	-53,416 Reduced 77.43%	15,573 $49,000
Q2 2022 Aug 15, 2022	BUY	$2.14 - $5.23 $112,921 - $275,971	52,767 Added 325.28%	68,989 $190,000
Q1 2022 May 16, 2022	BUY	$5.1 - $13.06 $14,356 - $36,763	2,815 Added 21.0%	16,222 $83,000
Q4 2021 Feb 14, 2022	BUY	$8.41 - $16.71 $39,779 - $79,038	4,730 Added 54.51%	13,407 $167,000
Q3 2021 Nov 15, 2021	BUY	$15.81 - $28.39 $137,183 - $246,340	8,677 New	8,677 $142,000

637K

Ticker GRPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,211,200
Description
Graphite Bio, Inc., a clinical-stage gene editing company, engages in developing therapies for serious and life-threatening diseases in the United States. It offers GPH101, a gene-edited autologous hematopoietic stem cell product candidate to directly correct the mutation that causes sickle cell disease and restore normal adult hemoglobin expres...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.